Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
204.00    -6.00 (-2.86%)
Bid:
203.50
Ask:
204.50
Spread: 1.00 (0.491%)
Market Cap: £543.69m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

28 Apr 2025 12:32

RNS Number : 4662G
Costain Group PLC
28 April 2025
 

 

 

Costain Group PLC (the 'Company')

28 April 2025

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the final dividend for the year ending 31 December 2024 is 104.88 pence per ordinary share.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 17 April 2025.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the final dividend for the year ending 31 December 2024 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 7 May 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The final dividend for the year ending 31 December 2024, including the scrip dividend, will be paid on 29 May 2025 (the dividend payment date), subject to approval at the 2025 Annual General Meeting on 15 May 2025, to the ordinary shareholders of the Company on the register at close of business on 22 April 2025 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

Investors and analysts

Matt Jones, Costain

matt.jones@costain.com

+44 (0)7860 922341

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997365

Charlie Twigg

+44 (0) 7946 494568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUBPCUPAGGR
Date   Source Headline
1st Nov 201911:05 amRNSTotal Voting Rights and Capital
28th Oct 20194:13 pmRNSHolding(s) in Company
28th Oct 20197:00 amRNSNEW CONTRACT AWARDS ACROSS THE HIGHWAYS SECTOR
18th Oct 201911:01 amRNSDirector/PDMR Shareholding
16th Oct 20197:00 amRNSSOUTHERN WATER SELECTS COSTAIN JV AS AMP7 PARTNER
15th Oct 20198:01 amRNS2019 Interim Dividend - Scrip Alternative
11th Oct 201911:35 amRNSHolding(s) in Company
25th Sep 20191:00 pmRNSDirector Declaration
23rd Sep 20194:28 pmRNSDirector/PDMR Shareholding
19th Sep 201911:52 amRNSScrip Dividend Reference Price
12th Sep 201910:21 amRNSHolding(s) in Company
21st Aug 20197:00 amRNSHalf-year Report
16th Aug 201910:26 amRNSHolding(s) in Company
5th Aug 201911:36 amRNSHolding(s) in Company
29th Jul 20194:49 pmRNSHolding(s) in Company
25th Jul 20194:54 pmRNSHolding(s) in Company
24th Jul 20193:53 pmRNSHolding(s) in Company
12th Jul 201910:07 amRNSHolding(s) in Company
9th Jul 20197:00 amRNSCostain to deliver Gatwick station redevelopment
5th Jul 201911:56 amRNSHolding(s) in Company
3rd Jul 20193:37 pmRNSHolding(s) in Company
2nd Jul 20194:01 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSCapital Markets Event
1st Jul 201910:32 amRNSBlock listing six monthly return
28th Jun 20197:00 amRNSTrading Update
25th Jun 20197:00 amRNSUnited Utilities framework contract
31st May 201910:33 amRNSTotal Voting Rights and Capital
15th May 20197:00 amRNSDividend - Scrip Alternative
8th May 201910:31 amRNSGrant of nil cost options
7th May 20194:50 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
3rd May 201912:02 pmRNSDirector/PDMR Shareholding
2nd May 201912:38 pmRNSHolding(s) in Company
1st May 20198:59 amRNSTotal Voting Rights and Capital
18th Apr 201911:11 amRNSScrip Dividend Reference Price
10th Apr 201910:27 amRNSDirector/PDMR Shareholding
3rd Apr 20192:51 pmRNSDirector/PDMR Shareholding
3rd Apr 20198:57 amRNSLong Term Incentive Plan - Listing Application
29th Mar 20199:02 amRNSTotal Voting Rights and Capital
22nd Mar 201910:53 amRNSNotice of AGM
22nd Mar 20197:00 amRNSCostain appointed to deliver A19 improvements
20th Mar 20197:00 amRNSCostain selected as AMP7 delivery partner
6th Mar 20197:00 amRNSFinal Results
6th Mar 20197:00 amRNSCEO Succession
1st Mar 20199:55 amRNSTotal Voting Rights
26th Feb 20198:32 amRNSHolding(s) in Company
25th Feb 20192:18 pmRNSHolding(s) in Company
6th Feb 201911:56 amRNSHolding(s) in Company
15th Jan 201911:49 amRNSHolding(s) in Company
9th Jan 201911:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.